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Background
Valve surgery in patients with previous CABG and patent
arterials conducts is a challenging procedure. To avoid any
risk of injury the grafts, we performed valve surgery with
the beating heart: 4 aortic valve replacement (AVR); 1
ascending aorta replacement and 2 mitral valve replace-
ment (MVR).
Methods
From September 2010 up to May 2013 seven patients
(four male and three female, aged 67,66 ± 10,85, pre op
LVEF 47,85 ± 6,46) with a story of previous CABG (three
patients using left internal mammary artery + saphenous
vein; four patients using LIMA + radial artery; one patient
using also the right internal mammary artery, number of
by pass 2.85 ± 0.63) were admitted in our department for
valvular or ascending aorta disease. All patients had
previous coronarography with patent arterial conduit in
six patients, while in one patient an occluded LIMA graft
on the LAD and a patent radial artery graft from the
LIMA on the first and second obtuse marginal were
observed. Reoperations were performed on beating heart.
Arterial conducts were not isolated to avoid possible injury
and the procedures were performed cross-clamping the
aorta, on pump, perfusing the coronary trough the patents
graft and with a retrograde perfusion with a cannula in the
coronary sinus.
Results
The aortic cross clamp time was 81,8±20,1. Two patients
had AVR with biological valve, two patients had AVR with
mechanical valve, one patient had replacement of the
ascending aorta with a dacron graft and two patients had
MVR with biologic valve. No major complications were
observed. No in hospital mortality was observed and all
patients were discharged in 6,5 ± 0,9 days post op, show-
ing a LVEF of 49,28 ± 5,62.
Conclusion
Beating heart surgery is a safe procedure in patients who
received a previous CABG. Maintaining coronary perfu-
sion through the patents arterial conducts and through
the retrograde perfusion will protect the heart without
any ischemia.
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